google-site-verification: googlee931399f3c92677c.html
top of page


BREAKING NEWS: Oct 2021 - US Kidney Research Corporation has been chosen as an award winner of the international KidneyX Phase 1 Artificial Kidney Contest for its novel development of a dialysate-free waterless portable and implantable artificial kidney technology. The $650,000 prize will be used to further our company’s research. Companies from around the world applied to the third-round contest. Six companies were selected as winners.
Read Press Release

SEE OUR COMPANY VIDEO Presented by KidneyX. Click Here

NEWS - US Kidney Research Corporation (USKRC) is the first in the world to produce synthetic urine from a device other than dialysis.. Read Press Release

US Kidney Research Corp Granted US Patent Press Release

Communications Materials, one of the Nature family of journals, has published a scientific article written by Dr Ira Kurtz and colleagues.
Simulating nephron ion transport function using activated wafer electrodeionization

Artificial Kidney Article by UCLA Health. Click here

GE Website (Scroll Down)    The Five Coolest Things On Earth

Curion Research Corp (now US Kidney Research Corporation) a Winner of the KidneyX Redesign Dialysis Phase 1 Contest.

Washington D.C., April 2019 - Curion Research Corporation is chosen as an award winner of the KidneyX Redesign Dialysis contest based on its novel "waterless feedback/sensor controlled blood purifying technology”, a first in the industry. The award was presented by the US Dept. of Health and Human Services and the American Society of Nephrology. 

Press Releases

News Stories

US Dept of Human and Health Services 

HHS and the American Society of Nephrology Award KidneyX Redesign Dialysis Phase 1 Winners

Company News

Company Name Change

Our former Name, Curion Research Corporation, was recently changed to US Kidney Research Corporation. The name change was needed to create a solo identity, due to several other US businesses using the name Curion. 


In vivo testing is planned for mid to late summer 2019. Data resulting from testing will be evaluated and used to make any needed improvements in functionality, quality or safety.

Status -1st Animal Study Completed

              2nd Animal Study Completed 

BioWorld MedTech
bottom of page